CCL2 (Carlumab) -VcMMAE Antibody
Anti-CCL2 (Carlumab) -VcMMAE is an antibody-drug conjugate (ADC) composed of the human-derived anti-CCL2 antibody Carlumab, linked with valine-citrulline (vc) and tubulin inhibitor MMAE. The toxic moiety and linker in the ADC are McMMAE. Anti-CCL2 (Carlumab) -VcMMAE can induce apoptosis and is utilized in cancer research.
Product Specifications
Target
Antibody-Drug Conjugates (ADCs), CCR, Microtubule Associated, Apoptosis
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation, Infectious Disease & Virology, Pharmacology & Drug Discovery, Signal Transduction
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680029-100 1x 100 µL
Fibronectin (TV-1), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC551037-100 1x 100 µL
CD44 Standard (DF1485), CF555 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940270-100 1x 100 µL
Fibronectin (HFN7.1), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740994-100 1x 100 µL
TNF alpha (J2D10), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 